87. Pulmonary veno-occlusive disease Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 3 / Drugs : 4 - (DrugBank : 3) / Drug target genes : 4 - Drug target pathways : 45
Pulmonary veno-occlusive disease and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
ID | Diseases (Sorted by drug repositionability) |
---|---|
87 | Pulmonary veno-occlusive disease |
13 | Multiple sclerosis/Neuromyelitis optica |
34 | Neurofibromatosis |
85 | Idiopathic interstitial pneumonia |
86 | Pulmonary arterial hypertension |
89 | Lymphangioleiomyomatosis |
88 | Chronic thromboembolic pulmonary hypertension |
35 | Pemphigus |
162 | Pemphigoid |
28 | Systemic amyloidosis |
8 | Huntington disease |
51 | Scleroderma |
46 | Malignant rheumatoid arthritis |
6 | Parkinson disease |
227 | Osler disease |
2 | Amyotrophic lateral sclerosis |